Related Experiment Videos

Vaccines for gonorrhea: where are we on the curve?

M S Blake1, L M Wetzler

  • 1University of Iowa, College of Medicine, Department of Microbiology, Iowa City, Iowa, USA.

Trends in Microbiology
|December 1, 1995
PubMed

Insights

Human antibodies targeting the gonococcal outer membrane can influence disease and transmission. Careful selection of antigens is crucial for developing a gonococcal vaccine that elicits only protective antibodies.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Human antibodies interacting with the gonococcal outer membrane play a role in modulating Neisseria gonorrhoeae transmission and disease progression.
  • The impact of these antibody-antigen interactions can be either beneficial to the host or advantageous to the bacteria.

Purpose of the Study:

  • To investigate the dual role of antibody binding to gonococcal antigens in disease modulation.
  • To identify strategies for developing an effective gonococcal vaccine by understanding antibody-mediated effects.

Main Methods:

  • Analysis of antibody binding to various gonococcal outer membrane antigens.
  • Assessment of the host-protective versus bacteria-promoting effects of elicited antibodies in relevant models (details not provided in the abstract).

Main Results:

  • Antibody binding to specific gonococcal antigens can have opposing effects, favoring either the host or the pathogen.
  • The outcome of antibody-mediated modulation is antigen-dependent.

Conclusions:

  • Developing an effective gonococcal vaccine is achievable.
  • Vaccine success hinges on the precise selection and formulation of gonococcal antigens that exclusively induce host-protective antibodies, avoiding those that might benefit the bacteria.

Related Concept Videos